Literature DB >> 23155269

Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.

Hemamali Samaratunga1, Dinithi Samaratunga, Nigel Dunglison, Joanna Perry-Keene, James Nicklin, Brett Delahunt.   

Abstract

Neoplasms commonly associated with alpha-fetoprotein (AFP) production are hepatocellular carcinomas and some germ cell tumors, typically yolk sac tumor. Rare tumors of visceral origin may also be associated with AFP production and those exhibiting a distinctive morphology are now known as hepatoid adenocarcinomas. To date, eight such tumors have been reported from the bladder and a further four from the renal pelvis. We report a unique case of a mixed hepatoid adenocarcinoma and urothelial carcinoma of the renal pelvis and ureter, in which both components were found to express AFP. An 84-year-old woman with a serum AFP level of 701 ng/ml was found to have advanced high-grade renal pelvi-calyceal and ureteral urothelial carcinoma exhibiting focal hepatoid adenocarcinoma differentiation. Both components displayed strong immunostaining for AFP. The patient was treated by radical nephro-uretectomy and postoperatively the serum AFP level declined to normal at a rate commensurate with its biological half-life. The presence of AFP expression in both the urothelial and hepatoid components of the tumor suggest that the molecular pathway changes associated with AFP production precede the hepatoid differentiation of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23155269

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge.

Authors:  Jon Arne Søreide; Ole Jacob Greve; Einar Gudlaugsson; Svein Størset
Journal:  Scand J Gastroenterol       Date:  2016-01-05       Impact factor: 2.423

2.  Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer.

Authors:  Zhu Li; Xu Hou; Juan Chen; Huidong Sun; Yuetang Mi; Yongling Sui; Yuhong Li; Jiaping Xie; Yingli Qiao; Xiaofeng Lei; Xiaoshuang Che; Jun Liu
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

3.  Yolk sac tumor differentiation in urothelial carcinoma of the urinary bladder: a case report and differential diagnosis.

Authors:  Nadia Espejo-Herrera; Enric Condom-Mundó
Journal:  Diagn Pathol       Date:  2020-06-03       Impact factor: 2.644

Review 4.  Unusual Faces of Bladder Cancer.

Authors:  Claudia Manini; José I López
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

Review 5.  Urachal yolk sac tumor penetrating the bladder as a diagnostic challenge: a case report and review of the literature.

Authors:  Vladimír Šámal; Tomáš Jirásek; Vít Paldus; Igor Richter; Ondřej Hes
Journal:  Diagn Pathol       Date:  2022-01-14       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.